A new nationwide study out of Taiwan adds fresh weight to the growing list of potential benefits offered by GLP-1 receptor agonists (GLP-1RAs)—a class of medications already known for their glycemic control, cardiovascular protection, and weight loss benefits. This time, the focus is on something more insidious: infections that land people in the hospital. In... Continue Reading →